ArticleScientific reports2025
Proactive recognition and early detection in communities through targeted HIV screening.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- HIV-1 and Artificial Intelligence: From Molecular Insight to Population Impact.Journal of AIDS and HIV treatment · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human Immunodeficiency Virus (HIV) remains a critical public health concern, and is a significant global health challenge, particularly in developing countries. Early HIV detection supports targeted interventions, and substantially reduce the HIV burden. In many resource-limited settings, early detection of HIV is hindered by stigma, limited access to testing, and low risk awareness. This study aims to enhance HIV screening in resource-limited settings by employing machine learning models to predict HIV risk using demographic and lifestyle variables. We analyzed data from 39,295 individuals in Shiraz, Iran, identifying key predictors, including drug injection, age, having a spouse with a history of HIV, occupation, and prison record. We trained and validated an Extreme Gradient Boosting (XGBoost) model using stratified five-fold cross-validation on the dataset. The XGBoost model achieved high accuracy (0.89; Confidence Interval (CI) 95% [0.88-0.89]), very-good discriminatory ability (Area Under the ROC Curve (AUC = 0.84 [0.83-0.84], with a fair-to-good agreement (Cohen's Kappa of 0.51 [0.51-0.52]). Moreover, the performance of the proposed method (PREDICT-HIV) was consistent across test folds. Our findings align with previous studies, emphasizing the importance of socio-demographic and behavioral factors in HIV risk prediction. The model's robustness suggests its potential for practical implementation, aiding early identification and intervention in high-risk groups. Future research should incorporate additional socioeconomic variables and validate the model in diverse populations to enhance global HIV prevention efforts. The web application, implemented using the Django framework, is freely available online for public access. PREDICT-HIV may support earlier identification and intervention in underserved populations, improving the efficiency of HIV screening programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.